Anca Butuca

2A Lucian Blaga Str
Sibiu, SB 550169, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Metabolic and Inflammatory Adverse Drug Reactions Associated with Amlodipine: A Descriptive and Disproportionality Analysis of EudraVigilance Reports.

Metabolic and Inflammatory Adverse Drug Reactions Associated with Amlodipine: A Descriptive and Disproportionality Analysis of EudraVigilance Reports.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 01, 2026

Digoxin Dosing Errors, Drug Interactions and Off-Label Risks: Insights from an EudraVigilance Disproportionality Analysis.

Digoxin Dosing Errors, Drug Interactions and Off-Label Risks: Insights from an EudraVigilance Disproportionality Analysis.

Journal: Journal of clinical medicine

Published: June 28, 2026

Metabolic Disturbances Associated with Beta-Blocker Therapy: New Insights from a Large-Scale Pharmacovigilance Study.

Metabolic Disturbances Associated with Beta-Blocker Therapy: New Insights from a Large-Scale Pharmacovigilance Study.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 26, 2026

hs-CRP/HDL Ratio Across Obesity and Type 2 Diabetes Mellitus Phenotypes in Adults: A Cross-Sectional Study.

hs-CRP/HDL Ratio Across Obesity and Type 2 Diabetes Mellitus Phenotypes in Adults: A Cross-Sectional Study.

Journal: Diagnostics (Basel, Switzerland)

Published: May 04, 2026

Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions-A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data.

Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions-A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 28, 2026

Safety assessment for ibuprofen using disproportionality analysis: a decade of data from the Romanian national pharmacovigilance system.

Safety assessment for ibuprofen using disproportionality analysis: a decade of data from the Romanian national pharmacovigilance system.

Journal: Frontiers in pharmacology

Published: April 23, 2026

Systemic Inflammation and Survival in Stage IV Colorectal Cancer: A Retrospective Cohort Study.

Systemic Inflammation and Survival in Stage IV Colorectal Cancer: A Retrospective Cohort Study.

Journal: Journal of clinical medicine

Published: February 10, 2026

Contributions of Pharmacovigilance to the Understanding of Risks Associated with Ibuprofen: Descriptive and Disproportionality Analysis Using FAERS Data.

Contributions of Pharmacovigilance to the Understanding of Risks Associated with Ibuprofen: Descriptive and Disproportionality Analysis Using FAERS Data.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: January 21, 2026

An Overview of Anticoagulant Drugs Pharmacology, Therapeutic Approaches, Limitations and Perspectives.

An Overview of Anticoagulant Drugs Pharmacology, Therapeutic Approaches, Limitations and Perspectives.

Journal: Pharmaceutics

Published: December 16, 2025

Resistance, Ineffectiveness, and Off-Label Use Related to Cephalosporins from the Reserve Group-A Pharmacovigilance Signal Detection Study on EudraVigilance Database.

Resistance, Ineffectiveness, and Off-Label Use Related to Cephalosporins from the Reserve Group-A Pharmacovigilance Signal Detection Study on EudraVigilance Database.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 14, 2025

Pharmacovigilance Insights into Ibuprofen's Neuropsychiatric Safety: A Retrospective Analysis of EudraVigilance Reports.

Pharmacovigilance Insights into Ibuprofen's Neuropsychiatric Safety: A Retrospective Analysis of EudraVigilance Reports.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 22, 2025

Exploring the Cardiovascular Safety Profile of Ibuprofen: Insights from EudraVigilance Database.

Exploring the Cardiovascular Safety Profile of Ibuprofen: Insights from EudraVigilance Database.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 16, 2025

Showing 1-12 of 36

Last Updated: 09/26/2026